TY  - JOUR

T1  - OT1-01-03: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study Comparing Denosumab with Placebo as Adjuvant Treatment for Women with Early-Stage Breast Cancer Who Are at High Risk of Disease Recurrence (D-CARE).

JO  - Ongoing Clinical Trials Poster Session Abstracts

PY  - 2011/12/15

AU  - Goss PE

AU  - Barrios CH

AU  - Bell R

AU  - Finkelstein D

AU  - Iwata H

AU  - Martin M

AU  - Braun A

AU  - Ke C

AU  - Maniar T

AU  - Braun S

AU  - Dansey R et al

ED  - 

DO  - DOI: 10.1158/0008-5472.sabcs11-ot1-01-03

PB  - American Association for Cancer Research

Y2  - 2025/10/10

ER  -